Abequolixron

N/A

Report date: 2024/05/06 14:41:11
NME

Base Information

Drug NameAbequolixron
Drug Alias NameRGX-104SB-742881
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLiver X receptor agonists
TargetsLiver X receptor
Therapy Area/IndicationsEndometrial NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesInspirna Inc
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A